Impact of ABCB1 single‐nucleotide variants on early, extremely severe neutropenia induced by paclitaxel/nanoparticle albumin‐bound paclitaxel in patients with gastric cancer
British Journal of Clinical Pharmacology · 2025
DOI: 10.1111/bcp.16359 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Akimitsu Maeda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan. Hauptthemen laut MEDLINE: Neutropenia, Stomach Neoplasms, Paclitaxel, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Aims
Paclitaxel and nanoparticle albumin‐bound (nab)‐paclitaxel can cause early, extremely severe neutropenia, occasionally leading to fatal outcomes. As paclitaxel is a substrate of P‐glycoprotein, this study aimed to investigate the impact of ABCB1 single‐nucleotide variants, which encode P‐glycoprotein, on early, extremely severe neutropenia in patients receiving paclitaxel/nab‐paclitaxel plus ramucirumab as second‐line therapy for unresectable advanced/recurrent gastric cancer.
Methods
We analysed patients treated at Aichi Cancer Center Hospital from January 2018 to August 2023, with DNA samples stored in the Cancer BioBank Aichi. The impact of ABCB1 variants T1236C (rs1128503), G2677T/A (rs2032582) and C3435T (rs1045642) on early, extremely severe neutropenia was examined. Neutropenia was defined as a decline in neutrophil count to
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.
- Division of Cancer Epidemiology and Prevention, Aichi Cancer Center, Nagoya, Aichi, Japan.
- Division of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
- Department of Cellular and Molecular Function Analysis, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan.
- Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.
- Department of Endoscopy, Aichi Cancer Center Hospital, Nagoya, Aichi, Japan.
ORCID-Profile: Akimitsu Maeda
Zitieren
APA
Maeda, A., Matsuo, K., Ando, H., Morishige, J. I., Muro, K., Uchida, K., & Tajika, M. (2025). Impact of ABCB1 single‐nucleotide variants on early, extremely severe neutropenia induced by paclitaxel/nanoparticle albumin‐bound paclitaxel in patients with gastric cancer. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16359
Vancouver
Maeda A, Matsuo K, Ando H, Morishige JI, Muro K, Uchida K, et al. Impact of ABCB1 single‐nucleotide variants on early, extremely severe neutropenia induced by paclitaxel/nanoparticle albumin‐bound paclitaxel in patients with gastric cancer. British Journal of Clinical Pharmacology. 2025. doi:10.1111/bcp.16359
BibTeX
@article{Maeda2025,
author = {Maeda, Akimitsu and Matsuo, Keitaro and Ando, Hitoshi and Morishige, Jun-Ichi and Muro, Kei and Uchida, Kosaku and Tajika, Masahiro},
title = {Impact of ABCB1 single‐nucleotide variants on early, extremely severe neutropenia induced by paclitaxel/nanoparticle albumin‐bound paclitaxel in patients with gastric cancer},
journal = {British Journal of Clinical Pharmacology},
year = {2025},
doi = {10.1111/bcp.16359}
}
EUVIMED